Shih-hsun Chen is a Senior Scientist at CSL with experience in developing downstream processes for monoclonal antibody products. Previously, Shih-hsun worked as an Associate Researcher at the Development Center for Biotechnology, focusing on developing manufacturing processes for recombinant E. Shih-hsun holds a Doctor of Philosophy degree in Biochemistry from the University of Adelaide.
CSL
54 followers
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives.